Cargando…
A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel
AIMS AND METHODS: This was a 6-month, open label, multinational, observational study in hypogonadal men treated with daily titrated dose of 50, 75, or 100 mg 1% testosterone gel (AndroGel®) in community practice. Primary outcome was effect of treatment on hypogonadal symptoms and quality of life as...
Autores principales: | Pexman-Fieth, Claire, Behre, Hermann M., Morales, Alvaro, Kan-Dobrosky, Natalia, Miller, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956632/ https://www.ncbi.nlm.nih.gov/pubmed/24274081 http://dx.doi.org/10.3109/13685538.2013.858113 |
Ejemplares similares
-
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
por: Jones, T. Hugh, et al.
Publicado: (2011) -
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009) -
Is testosterone involved in low female sexual desire?
por: Abdo, Carmita H. N.
Publicado: (2019) -
Depression, testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV infection
por: Amini Lari, Mahmood, et al.
Publicado: (2012) -
Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)